Glaxo inches up ahead of FDA meeting
July 12, 2010 at 10:32 AM EDT
Shares of U.K. pharmaceutical giant GlaxoSmithKline PLC increase marginally in early trading, the day before U.S. regulators are scheduled to meet to discuss the safety of one of the company's biggest selling products, the diabetes drug Avandia.
